ARTICLE https://harbor-dev.pubfactory.com/view/journals/jnccn/9/3/article-p257.xml Industry “Rewrites” of NCCN Guidelines 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/3/article-p261.xml Is the Battle Over Bevacizumab Coverage Looming? 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/3/article-p265.xml Access to and Appropriateness of Cancer Care: Who Decides? 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/3/article-p268.xml Development and Validation of 11 Symptom Indexes to Evaluate Response to Chemotherapy for Advanced Cancer 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/3/article-p280.xml Acute Myeloid Leukemia 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/3/article-p319.xml Identifying Older Patients With Acute Myeloid Leukemia Who May Be Candidates for Reduced-Intensity Hematopoietic Cell Transplantation 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/3/article-p331.xml Novel Agents for the Treatment of Acute Myeloid Leukemia in the Older Patient 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/3/article-p337.xml Treatment of Acute Promyelocytic Leukemia for Older Patients 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/3/article-pxx.xml NCCN News 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/3/article-pxxiv.xml Oncology Research Program 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/3/article-pxxviii.xml Adjuvant Chemotherapy Regimens for Breast Cancer 2019-01-02